Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01222377 · ClinicalTrials.gov registry record · NA
Endoscopic Breast Surgery in Treating Patients With Breast Cancer
A NA study, sponsored by University of Southern California.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01222377 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 2 participants.
The verdict
NCT01222377, a NA study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
RATIONALE: Endoscopic breast surgery (EBS) is a less invasive type of surgery for breast cancer and may have fewer side effects and improve recovery. PURPOSE: This clinical trial studies endoscopic breast surgery in treating patients with breast cancer.
Interventions
- PROCEDURE quality-of-life assessment
- PROCEDURE endoscopic surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01222377
The ClinicalTrials.gov registry entry for NCT01222377 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which quality-of-life assessment is the first listed.
NCT01222377 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01222377 about?
NCT01222377 is a clinical study titled "Endoscopic Breast Surgery in Treating Patients With Breast Cancer". RATIONALE: Endoscopic breast surgery (EBS) is a less invasive type of surgery for breast cancer and may have fewer side effects and improve recovery. PURPOSE: This clinical trial studies endoscopic breast surgery in treating patients with breast cancer.
What is the current status of trial NCT01222377?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2010-09. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01222377?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), endoscopic surgery (PROCEDURE).
Who is sponsoring clinical trial NCT01222377?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.